NEW YORK (GenomeWeb News) - BioNanomatrix and Princeton University will use a $200,000 grant from the National Cancer Institute to develop a nanofluidics technology for cell fractionation, the company said today.
 
Under the two-year Small Technology Transfer Research grant, BioNanomatrix and Princeton’s Institute for the Science and Technology of Materials will develop a front-end sample-sorting component for the company’s BioNanomatrix whole-genome analytic platform.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two new Reproducibility Project: Cancer Biology studies have largely reproduced the original findings, ScienceInsider reports.

DNA fingerprinting could catch some sample mix-ups at pathology labs, the New York Times says.

A Maryland police department has turned to DNA phenotyping to develop a suspect sketch, WJLA reports.

In Cell this week: DNA methylation and T cell exhaustion, longevity in C. elegans, and more.